Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 6 August 2009, Vol. 114, No. 6, pp. 1138-1139.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Kyrle, P. A.
Right arrow Articles by Eichinger, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyrle, P. A.
Right arrow Articles by Eichinger, S.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

VASCULAR BIOLOGY

Comment on Brooks et al, page 1276

Is Virchow's triad complete?

Paul A. Kyrle, and Sabine Eichinger

MEDICAL UNIVERSITY OF VIENNA

In this issue of Blood, Brooks and colleagues report on a thromboresistant phenotype of venous valve sinus endothelium as compared to vein luminal endothelium.

Venous thrombi are formed in the setting of low flow and low shear stress and mainly consist of fibrin strands, red blood cells, and a few platelets. In 1856, Rudolf Virchow postulated that abnormalities in blood flow, hypercoagulability of the blood, and injury to the vessel wall are causally related to thrombus formation (see figure). Reduced venous blood flow during, for instance, immobilization, prolonged bed rest, limb paresis, long-distance travel, or in obese or pregnant individuals, has been convincingly shown to increase the risk of deep vein thrombosis (DVT).1 In keeping with Virchow's concept, alterations of the coagulation system that induce a hypercoagulable state also confer an increased risk of DVT. For example, patients with high clotting factor levels have an increased risk of both a first and a recurrent DVT.25 Alterations of the vessel wall that lead to plaque formation and plaque rupture play a key role in the development and progression of arterial occlusive disease. However, whether the vessel wall itself plays a role in the development of venous thrombosis is less clear.


Figure 1
View larger version (45K):
[in this window]
[in a new window]

 
Virchow's triad. Professional illustration by Kenneth X. Probst.

 
In an elegant study, Brooks et al address this important aspect. They explored the procoagulant and anticoagulant properties of the venous valve sinus endothelium in comparison to the vein lumenal endothelium.6 Compared with the vein lumenal endothelium, expression of endothelial protein C receptor (EPCR) and thrombomodulin (TM) was increased in valvular sinus endothelium while the expression of von Willebrand factor (VWF) was reduced. In other words, what they found was an up-regulation of anticoagulant (EPCR, TM) and a down-regulation of procoagulant (VWF) properties of the valvular sinus endothelium. From this observation, they conclude that valve pockets have a more thromboresistant phenotype. Along this line, they speculate that variations of this valvular sinus endothelial thromboresistance may be associated with a propensity toward venous thrombosis. This would further support the common notion that in patients with DVT of the lower limbs, thrombus formation preferentially starts in the valve pockets of the veins of the calf and then extends to the proximal veins.7

These findings are intriguing as they bring alterations of the vessel walls into focus when considering the multiple pathomechanisms leading to venous thrombosis. Nevertheless, whether a shift in the procoagulant and anticoagulant balance of particular sections of the endothelium will emerge as a novel risk factor of venous thrombosis is still an open question as there are some limitations to the study. The authors studied great saphenous veins, which were removed during coronary artery bypass crafting. Thrombosis can occur in various segments of the venous system including the cerebral sinus veins, splanchnic veins, and deep veins of the upper and lower extremities. These veins differ in flow conditions and anatomic features, mainly in the presence and number of valves. It needs to be investigated whether the findings of Brooks et al can be extrapolated to other parts of the venous system, in particular to the deep veins of the legs, where the majority of thrombotic events occur. A further limitation of the study is the rather small number of specimens investigated.

This study opens the door to further important research, as the mechanisms responsible for the procoagulant and anticoagulant properties of the endothelium are manifold. The authors studied some important components of the vessel wall, namely the anticoagulant protein C pathway and the procoagulant VWF. Many more vascular bed–specific pathways, including fibrinolysis, inflammation, and tissue factor to name just a few, should be considered in future studies.

Venous thrombosis is regarded as a multifactorial disease. However, in a substantial proportion of thrombosis patients, a risk factor of thrombosis is not detectable. It can easily be speculated that, at least in some of these patients, a shift in the balance between procoagulant and anticoagulant forces of the endothelium is responsible for their thrombotic tendency. This study should foster further research to unravel the role of the vessel wall in the pathogenesis of DVT, thereby bringing Virchow's triad finally to full realization.

Footnotes

Conflict-of-interest disclosure: The authors declare no competing financial interests. {blacksquare}

REFERENCES

  1. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet. 2005;365:1163–1164.[CrossRef][Medline] [Order article via Infotrieve]

  2. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152–155.[CrossRef][Medline] [Order article via Infotrieve]

  3. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678–3682.[Abstract/Free Full Text]

  4. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457–462.[Abstract/Free Full Text]

  5. Weltermann A, Eichinger S, Bialonczyk C, et al. The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost. 2003;1:28–32.[CrossRef][Medline] [Order article via Infotrieve]

  6. Brooks EG, Trotman W, Wadsworth MP, et al. Valves of the deep venous system: an overlooked risk factor. Blood. 2009;114:1276–1279.[Abstract/Free Full Text]

  7. Nicolaides AN, Kakkar VV, Field ES, Renney JT. The origin of deep vein thrombosis: a venographic study. Br J Radiol. 1971;44:653–663.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Valves of the deep venous system: an overlooked risk factor
Erin G. Brooks, Winifred Trotman, Marilyn P. Wadsworth, Douglas J. Taatjes, Mark F. Evans, Frank P. Ittleman, Peter W. Callas, Charles T. Esmon, and Edwin G. Bovill
Blood 2009 114: 1276-1279. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Kyrle, P. A.
Right arrow Articles by Eichinger, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyrle, P. A.
Right arrow Articles by Eichinger, S.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020